Tobacco smoking and bipolar disorder

被引:108
作者
Gonzalez-Pinto, A
Gutierrez, M
Ezcurra, J
Aizpuru, F
Mosquera, F
Lopez, P
de Leon, J
机构
[1] Univ Kentucky, Eastern State Hosp, Mental Hlth Res Ctr, Lexington, KY 40508 USA
[2] Santiago Apostol Hosp, Vitoria, Alava, Spain
关键词
D O I
10.4088/JCP.v59n0503
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Background: We sought to determine whether tobacco smoking is associated with bipolar disorder. Method: This case-control study carried out in Alava, in the north of Spain, included patients with a DSM-LII-R diagnosis of bipolar disorder type I (N = 51) and a representative sample of the normal population (N = 517). Smoking history of bipolar patients was assessed with the Fagerstrom Test for Nicotine Dependence and was verified by family members of the patients. Results: The frequencies of ever smoking and current daily smoking were, respectively, 63% (32/51) and 51% (26/51) for the bipolar patients and 45% (235/517) and 33% (169/517) for the control group (respective odds ratios [ORs] and 95% confidence intervals [CIs] were OR = 2.0, 95% CI = 1.1 to 3.8 and OR = 2.1, 95% CI = 1.2 to 4.0). The differences were significant (p = .03 and p = .042, respectively) for bipolar versus control males. Bipolar disorder tin both genders) was also significantly associated (OR = 4.4, 95% CI = 1.7 to 11.9, p = .0015) with heavy smoking (more than 1 pack per day). Conclusion: Despite its small sample size, this study suggests that smoking may be more prevalent in bipolar patients than in the normal population. Since most patients started to smoke before the onset of illness, vulnerability to bipolar illness may make subjects vulnerable to become tobacco smokers.
引用
收藏
页码:225 / 228
页数:4
相关论文
共 13 条
[1]  
ANITUA C, 1996, ENCUESTA SALUD PUBLI
[2]   Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions [J].
Bertz, RJ ;
Granneman, GR .
CLINICAL PHARMACOKINETICS, 1997, 32 (03) :210-258
[3]   Smoking and vulnerability for schizophrenia [J].
deLeon, J .
SCHIZOPHRENIA BULLETIN, 1996, 22 (03) :405-409
[4]  
DELEON J, 1995, AM J PSYCHIAT, V152, P453
[5]   Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus [J].
Freedman, R ;
Coon, H ;
MylesWorsley, M ;
OrrUrtreger, A ;
Olincy, A ;
Davis, A ;
Polymeropoulos, M ;
Holik, J ;
Hopkins, J ;
Hoff, M ;
Rosenthal, J ;
Waldo, MC ;
Reimherr, F ;
Wender, P ;
Yaw, J ;
Young, DA ;
Breese, CR ;
Adams, C ;
Patterson, D ;
Adler, LE ;
Kruglyak, L ;
Leonard, S ;
Byerley, W .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (02) :587-592
[6]  
GLASSMAN AH, 1993, AM J PSYCHIAT, V150, P546
[7]  
GONZALEZPINTO A, IN PRESS J AFFECT DI
[8]  
HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119
[9]  
HUGHES JR, 1986, AM J PSYCHIAT, V143, P993
[10]  
KENDLER KS, 1993, ARCH GEN PSYCHIAT, V50, P36